Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

Recent Pfizer patent reports new PET diagnostic agents

Aug. 3, 2006

GE Healthcare exercises option to U.S. rights for Hexvix

Aug. 3, 2006

Schering hit by insufficient results for sargramostim and Ultravist recall

Aug. 2, 2006

AMDL compiles FDA requested data for DR-70 cancer test

Aug. 2, 2006

NicAlert to be used in new smoking cessation study

Aug. 2, 2006

Recent GSK patent describes novel diagnostic agents

July 26, 2006

Schering and Avid to develop diagnostic imaging agents for Alzheimer's disease

July 18, 2006

Schering AG will not exercise option for EP-2104R

July 17, 2006

New phase II study for Lymphoseek

July 17, 2006

Alzheimer's disease diagnostics described in University of Pennsylvania patent

July 14, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...